Abstract
The laminins comprise of a family of heterotrimeric proteins of the extracellular matrix. The cross-shaped proteins consist of a heavy α-chain and two light chains, called β and γ. Each group of chains, classified on their sequence identity and domain organization, include different isoforms. A deficiency of the α2 chain of laminin-2, previously termed merosin or M component, was shown to be responsible for one form of congenital muscular dystrophy (CMD). We investigated muscle biopsies of 20 patients with the clinical diagnosis of CMD and histological evidence of muscular dystrophy for the expression of different laminin chains. Patients with evidence of pachygyria/lissencephaly of the CNS were excluded from this series. The immunohistochemical analysis was correlated to clinical findings and MRI data of the brain. Of 20 patients, 11 (55%) revealed complete or near-complete deficiency of the α2 chain in their skeletal muscle specimens. So far none of these patients became ambulant. Of 20 patients 2 showed partial but clear-cut α2 chain-deficiency. These two patients became ambulant at 18 months and 3 years. All 13 patients with complete or partial α2 chain-deficiency demonstrated cerebral white matter changes on MRI. In contrast, 6/7 CMD patients with normal α2 chain expression became ambulant and none of the 6/7 tested showed evidence of cerebral abnormal T2 sequence signal of the myelin on MRI.
Similar content being viewed by others
Abbreviations
- CK :
-
creatine kinase
- CMD :
-
congenital muscular dystrophy
- FCMD :
-
Fukuyama congenital muscular dystrophy
- MEB :
-
muscle eye brain disease
- WWS :
-
Walker-Warburg syndrome
References
Arahata K, Hayashi YK, Koga R et al. (1993) Laminin in animal models for muscular dystrophy: defect of laminin M in skeletal and cardiac muscles and peripheral nerve of the homozygous dystrophic dy/dy mice. Proc Jpn Acad 69:259–264
Brown JC, Timpl R (1994) The laminins. Matrix Biol 14: 275–281
Campbell KP, Ervasti JM (1993) A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 122:809–823
Dubowitz V (1994) Workshop report on 22nd ENMC sponsored meeting on congential muscular dystrophy held in Baarn, The Netherlands, May 14–16 1993. Neuromusc Disord 4: 75–81
Ehrig K, Leivo I, Agraves WS, Ruoslahti E, Engvall E (1990) Merosin, a tissue-specific basement membrane protein, is a laminin-like protein. Proc Natl Acad Sci USA 87: 3264–3268
Engvall E (1993) Laminin variants: why, where and when? Kidney Int 43: 2–6
Engvall E, Leivo I (1988) Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast is expressed late in nerve and muscle development. Proc Natl Acad Sci USA 85: 1544–1548
Engvall E, Earwicker D, Day A, Muir D, Manthorpe M, Paulsson M (1992) Merosin promotes cell attachement and neurite outgrowth and is a component of the neurite-promoting factor of RN22 Schwannoma cells. Exp Cell Res 198: 115–123
Fardeau M, Dubowitz V (1995) Proceedings of the 27th ENMC sponsored workshop on congenital muscular dystrophy 22–24 April 1994, The Netherlands. Neuromusc Disord 5: 253–258
Goodman SL, Deutzmann R, Mark K von der (1987) Two distinct cell-binding domains in laminin can independently promote nonneuronal cell adhesion and spreading. J Cell Biol 105: 589–598
Hayashi YK, Engvall E, Arikawa-Hirasawa E et al. (1993) Abnormal localization of laminin subunits in muscular dystrophies. J Neurol Sci 119: 53–64
Hayashi YK, Koga R, Tsukahara T et al. (1995) Deficiency of laminin α2-chain mRNA in muscle in a patient with merosin-negative congenital muscular dystrophy. Muscle Nerve 18: 1027–1030
Helbling-Leclerc A, Zhang X, Topaloglu H et al. (1995) Mutations in the laminin α2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet 11: 216–218
Hillaire D, Leclerc A, Fauré S et al. (1994) Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping. Hum Mol Genet 3: 1657–1661
Matsumura K, Campbell KP (1993) Deficiency of dystrophin-associated proteins: a common mechanism leading to muscle cell necrosis in severe childhood muscular dystrophies. Neuromuse Disord 2: 109–118
Muntoni F, Sewry C, Wilson L, Angelini C, Trevisan CP, Brambati B, Dubowitz V (1995) Prenatal diagnosis in congenital muscular dystrophy. Lancet 345: 591
Paulsson, M (1993) Laminin and collagen IV variants and heterogeneity in basement membrane composition. In: Timpl R, Rohrbach DH (eds) Molecular and cellular aspects of basement membranes. Academic Press, San Diego, pp 177–187
Philpot J, Topaloglu H, Pennock J, Dubowitz V (1995) Familial concordance of brain magnetic resonance imaging changes in congenital muscular dystrophy. Neuromusc Disord 5: 227–231
Philpot J, Sewry C, Pennock J, Dubowitz (1995) Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletal muscle. Neuromusc Disord 5: 301–306
Sewry C, Philpot J, Mahony D, Wilson LA, Muntoni F, Dubowitz (1995) Expression of laminin subunits in congenital muscular dystrophy. Neuromusc Disord 5: 307–316
Sewry CA, Chevallay M, Tomé FMS (1995) Expression of laminin subunits in human fetal skeletal muscle. Histochem J 27: 497–504
Straub V, Bittner, RE, Leger, JJ, Voit, T (1992) Direct visualization of the dystrophin network on skeletal muscle fiber membrane. J Cell Biol 119: 1183–1191
Sunada Y, Bernier SM, Kozak CA, Yamada Y, Campbell KP (1994) Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus. J Biol Chem 269: 13729–13732
Timpl R, Martin GR (1987) Laminin and other basement membrane components. Ann Rev Cell Biol 3: 57–85
Tomè FMS, Evangelista T, Leclerc A et al. (1994) Congenital muscular dystrophy with merosin deficiency. CR Acad Sci Paris 317: 351–357
Voit T, Haas K, Lèger JOC, Pons F, Lèger JJ (1991) Xp21 dystrophin and 6q2 dystrophin-related protein. Am J Pathol 139: 969–976
Voit T, Fardeau M, Tomé FMS (1994) Prenatal detection of merosin expression in human placenta. Neuropediatrics 25: 332–333
Voit T, Sewry CA, Meyer K et al. (1995) Preserved merosin M-chain (or laminin-α2) expression in skeletal muscle distinguishes Walker-Warburg Syndrome from Fukuyama Muscular Dystrophy and merosin-deficient Congenital Muscular Dystrophy. Neuropediatrics 26: 148–155
Vuolteenaho R, Nissinen M, Sainio K et al. (1994) Human laminin M chain (merosin): complete primary structure, chromosomal assignment, and expression of the M and A chain in human fetal tissues. J Cell Biol 124: 381–394
Xu H, Christmas P, Wu XR, Wewer UM, Engvall E (1994) Defective muscle basement membrane and lack of Mlaminin in the dystrophic dy/dy mouse. Proc Natl Acad Sci USA 91: 5572–5576
Xu H, Wu XR, Wewer UM, Engvall E (1994) Murine muscular dystrophy caused by a mutation in the laminin α2 (Lama2) gene. Nat Genet 8: 297–302
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Herrmann, R., Straub, V., Meyer, K. et al. Congenital muscular dystrophy with laminin α2 chain deficiency: Identification of a new intermediate phenotype and correlation of clinical findings to muscle immunohistochemistry. Eur J Pediatr 155, 968–976 (1996). https://doi.org/10.1007/BF02282889
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02282889